Prostaglandin G/H Synthase Isoenzyme 2 Expression in Fibroblasts - Regulation by Dexamethasone, Mitogens, and Oncogenes

doi:10.1006/abbi.1993.1496

Archives of Biochemistry and Biophysics

Volume 306, Issue 1, October 1993, Pages 169-177

https://doi.org/10.1006/abbi.1993.1496 Get rights and content

Abstract

Mitogens increase prostaglandin synthesis in fibroblasts. In the present studies, transcriptional activation of the prostaglandin G/H synthase isoenzyme 2 (PGHS-2) gene is shown to be responsible for this induction. Transcription of the PGHS-2 gene maximally increased within 15 mm of stimulation, and elevated cellular PGHS-2 mUNA, protein, and prostaglandin synthase activity were detected shortly thereafter. Pulse-chase experiments showed induced isoenzyme 2 is short lived, with a half-life of 22 mm in chicken embryo fibroblasts. Neoplastic transformation of fibroblasts by a variety of oncogenes induced either or both PGHS-1 and PGHS-2 mRNAs in immortalized murine NIH3T3 cells. Some preference of oncogenes such as v-src to induce PGHS2 mRNA has been previously observed. However, in this study exceptions in which v-src did not induce PGHS-2 mRNA were noted. Analysis of independent cell lines transformed by v-fes showed this oncogene induced both PGHS-1 and PGHS-2. Dexamethasone, a synthetic glucocorticoid, selectively decreased both basal and induced levels of PGHS-2 mRNA. Simultaneous addition of the steroid with mitogen reduced mitogen-induced PGHS-2 mRNA levels by 80%. However, nuclear run-on experiments failed to detect any decrease in PGHS-2 mRNA transcription. This suggested dexamethasone rapidly caused PGHS-2 mRNA destabilization. Cycloheximide blocked PGHS-2 mRNA decrease. A fibroblast cell line, RS2, was identified that contained only isoenzyme 2 and possessed PGHS activity that was more highly mitogen-inducible than in any other cell line yet described. Mitogen-inducible activity in RS2 cells was inhibited by aspirin, indicating that PGHS-2, like PGHS-1, can be inactivated by this drug.

References (0)

Cited by (124)

Anti-inflammatory drugs, eicosanoids and the annexin A1/FPR2 anti-inflammatory system
2012, Prostaglandins and Other Lipid Mediators
Citation Excerpt :
The two genes had a different chromosomal organization and Cox-l/Cox-2 mRNA was differentially expressed in human tissues [11]. There was a fundamental difference between the two genes, with the Cox-2 promoter containing elements suggesting it was activated during cellular stress and down-regulated by glucocorticoids, whereas the Cox-l promoter bore the hallmarks of a ‘housekeeping’ gene [12]. Histological and other studies confirmed this apparent functional split between the two enzymes and for example, Cox-1 was observed to be the predominant isoform in healthy gastrointestinal tissue from several species [13].
The action of anti-inflammatory and anti-allergic drugs on the eicosanoid system is briefly reviewed. In addition to the aspirin-like drugs, which directly inhibit the cyclo-oxygenase enzymes, other drugs such as the glucocorticoids and the cromones also inhibit the formation of eicosanoids. In the latter cases this is bought about through the release of a protein factor that acts through formyl peptide receptors on the target cell surface. Of growing interest, is the observation that this receptor is also a target for other eicosanoids, such as lipoxins and resolvins that modulate host defence systems.
Effects of n-6 polyunsaturated fatty acids on prostaglandin production in ovine fetal chorion cells in vitro in late gestation ewes
2011, Placenta
Citation Excerpt :
Glucocorticoids, including cortisol and the synthetic glucocorticoids, such as DEX and beta-methasone are effective anti-inflammatories. They have multiple sites of inhibition on PG production, including blocking PLA2 [38], inhibiting PGHS2 transcription and expression and destabilising PGHS2 [39,40]. On the other hand, cortisol is a key player in increasing intrauterine PG production to initiate parturition [9] by stimulating PGHS2 expression and inhibiting PGDH in intrauterine tissues, including FC [10,11].
To use an in vitro model of the ovine placenta to determine effects of n-6 polyunsaturated fatty acid (PUFA) supplementation on prostaglandin (PG) production. PGs are key regulators of fetal maturation and parturition.
Fetal allantochorion tissue (FC) was collected in late pregnancy (day 135). FC cells were isolated and cultured with 0–100 μM of linoleic acid (LA), γ-linolenic acid (GLA) or arachidonic acid (AA) in serum free medium and challenged with control medium, lipopolysaccharide (LPS, 0.1 μg/ml), dexamethasone (DEX, 5 μM) or a combination of LPS (0.1 μg/ml) with DEX (5 μM). Spent medium was harvested at 2 h and 24 h post challenge for measuring PGs.
To assess the effects of treatment on placental 1- and 2-series PGE production.
LA supplementation inhibited both PGE₁ and PGE₂ production. GLA predominantly stimulated PGE₁ generation, although it also increased PGE₂ production. AA supplementation predominantly increased PGE₂ production, but also stimulated PGE₁. DEX treatment with or without LPS inhibited PG production. Supplementation with n-6 PUFAs attenuated or neutralised the stimulatory effect of LPS challenge on FC cells for both PGE₁ and PGE₂ production.
These data show that supplementation with n-6 PUFAs alters placental PG production, but their precise effects depend on their position in the biosynthetic pathway for PG synthesis. This study supports the possibility that GLA containing oils, widely promoted as dietary supplements, might reduce the risk of pre-term labour by inhibiting the responsiveness of PGE₂ production to LPS challenge in the placenta.
Sulfuretin isolated from heartwood of Rhus verniciflua inhibits LPS-induced inducible nitric oxide synthase, cyclooxygenase-2, and pro-inflammatory cytokines expression via the down-regulation of NF-κB in RAW 264.7 murine macrophage cells
2010, International Immunopharmacology
It has been reported that Rhus verniciflua exhibits anti-inflammatory, anti-oxidant and anti-cancer activities. However, little is known about biological activity of sulfuretin, a flavonoid isolated from R. verniciflua. In the present study, we investigated the anti-inflammatory effect and the underlying molecular mechanisms of sulfuretin in lipopolysaccharide (LPS)-induced RAW 264.7 cells. Sulfuretin dose-dependently reduced the productions of nitric oxide (NO), prostaglandin E₂ (PGE₂), tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) induced by LPS. Consistent with these findings, sulfuretin significantly suppressed the LPS-induced expressions of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), TNF-α, and IL-1β. In addition, sulfuretin attenuated LPS-induced DNA binding and the transcriptional activities of nuclear factor-kappa B (NF-κB), which was accompanied by a parallel reduction of degradation and phosphorylation of inhibitory kappa B-α (IκB-α) and consequently by decreased nuclear translocation of p65 subunit of NF-κB. Furthermore, pretreatment with sulfuretin significantly inhibited the LPS-stimulated activation of IκB kinase β (IKKβ). Taken together, these results suggest that the anti-inflammatory effect of sulfuretin in LPS-treated RAW 264.7 macrophages is associated with the suppression of NF-κB transcriptional activity via the inhibitory regulation of IKKβ phosphorylation.
Hypertonic sodium choloride and mannitol induces COX-2 via different signaling pathways in mouse cortical collecting duct M-1 cells
2007, Life Sciences
The kidney cortical collecting duct is an important site for the maintenance of sodium balance. Previous studies have shown that, in renal medullary cells, hypertonic stress induces expression of cyclooxygenase-2 (COX-2) via NF-κB activation, but little is known about COX-2 expression in response to hypertonicity in the cortical collecting duct. Therefore, we examined the mechanism of hypertonic induction of COX-2 in M-1 cells derived from mouse cortical collecting duct. Induction of COX-2 protein was detected within 6 h of treatment with hypertonic sodium chloride. The treatment also increased COX-2 mRNA accumulation in a cycloheximide-independent manner, suggesting that ongoing protein synthesis is not required for COX-2 induction. Using reporter plasmids containing 0.2-, 0.3-, and 1.5-kb fragments of the COX-2 promoter, we found that hypertonic induction of COX-2 was due to an increase in promoter activity. The COX-2-inductive effect of hypertonicity was inhibited by SB203580, indicating that the effect is mediated by p38 MAPK. Since p38 MAPK can activate NF-κB, we made point mutations in the NF-κB binding site within the COX-2 promoter. The mutations did not block the induction of COX-2 promoter activity by hypertonic sodium chloride, and hypertonic sodium chloride failed to activate NF-κB binding site-driven reporter gene constructs. In contrast, hypertonic mannitol activated NF-κB, indicating that hypertonic mannitol and hypertonic sodium chloride activate COX-2 by different mechanisms. Thus, induction of COX-2 expression in M-1 cells by hypertonic sodium chloride does not involve activation of NF-κB. Furthermore, the signal transduction pathways that respond to hypertonic stress vary for different osmolytes in cortical collecting duct cells.
The 19-amino acid cassette of cyclooxygenase-2 mediates entry of the protein into the endoplasmic reticulum-associated degradation system
2006, Journal of Biological Chemistry
Citation Excerpt :
The plate was developed in ethyl acetate, 2,2,4-trimethylpentane, acetic acid, water (110:50:20:100) and exposed to x-ray film, and radioactive products were visualized by autoradiography. Rapid, Proteasome-dependent Degradation of COX-2—COX-1 is expressed constitutively in murine NIH/3T3 fibroblasts, whereas COX-2 is expressed inducibly and transiently (19–21). This raises the possibility that the protein stabilities of the COX isoforms are different with COX-2 being more susceptible to degradation.
Cyclooxygenase (COX) isoforms catalyze the committed step in prostaglandin biosynthesis. The primary structures of COX-1 and COX-2 are very similar except that COX-2 has a 19-amino acid (19-AA) segment of unknown function located just inside its C terminus. Here we provide evidence that the major role of the 19-AA cassette is to mediate entry of COX-2 into the ER-associated degradation system that transports ER proteins to the cytoplasm. COX-1 is constitutively expressed in many cells, whereas COX-2 is usually expressed inducibly and transiently. In murine NIH/3T3 fibroblasts, we find that COX-2 protein is degraded with a half-life (t_½) of about 2 h, whereas COX-1 is reasonably stable (t_½ >12 h); COX-2 degradation is retarded by 26 S proteasome inhibitors. Similarly, COX-1 expressed heterologously in HEK293 cells is quite stable (t_½ > 24 h), whereas COX-2 expressed heterologously is degraded with a t_½ of ∼5h, and its degradation is slowed by proteasome inhibitors. A deletion mutant of COX-2 was prepared lacking 18 residues of the 19-AA cassette. This mutant retains native COX-2 activity but, unlike native COX-2, is stable in HEK293 cells. Conversely, inserting the COX-2 19-AA cassette near the C terminus of COX-1 yields a mutant ins594–612 COX-1 that is unstable (t_½ ∼3 h). Mutation of Asn-594, an N-glycosylation site at the beginning of the 19-AA cassette, stabilizes both COX-2 and ins594–612 COX-1; nonetheless, COX mutants that are glycosylated at Asn-594 but lack the remainder of the 19-amino acid cassette (i.e. del597–612 COX-2 and ins594–596 COX-1) are stable. Thus, although glycosylation of Asn-594 is necessary for COX-2 degradation, at least part of the remainder of the 19-AA insert is also required. Finally, kifunensine, a mannosidase inhibitor that can block entry of ER proteins into the ER-associated degradation system, retards COX-2 degradation.
Inhibition of prostaglandin E<inf>2</inf> production by taiwanin C isolated from the root of Acanthopanax chiisanensis and the mechanism of action
2002, Biochemical Pharmacology
Citation Excerpt :
Two isoforms of COX have been identified, COX-1 and COX-2 [3,4]. The former is constitutively expressed in most tissues [5], while the latter is induced by bacterial lipopolysaccharide (LPS) [6], TPA [7], or cytokines such as interleukin-1β and tumor necrosis factor (TNF)-α [8,9] in macrophages [10], fibroblasts [11], and inflamed tissues [12,13]. However, according to recent reports, COX-2 is also constitutively expressed in the brain [14], kidney [15], and stomach mucosa [16].
Five lignans, l-sesamin, savinin, helioxanthin, taiwanin C, and cis-dibenzylbutyrolactone, were isolated from the root of Acanthopanax chiisanensis (Araliaceae), a Korean medicinal plant, and their inhibitory effects on the production of prostaglandin (PG) E₂ stimulated by 12-O-tetradecanoylphorbol 13-acetate (TPA) in rat peritoneal macrophages were examined. Among the five lignans, taiwanin C was the most potent ( $ic_{50} =0.12$ μM), followed by helioxanthin, cis-dibenzylbutyrolactone, and savinin. l-Sesamin had no effect. Taiwanin C showed no inhibitory effect on the TPA-induced release of radioactivity from $[^{3} H]$ arachidonic acid-labeled macrophages, nor did it inhibit the expression of cyclooxygenase (COX)-2 protein induced by TPA. However, the activities of isolated COX-1 and COX-2 were inhibited by taiwanin C ( $ic_{50} =1.06$ and 9.31 μM, respectively), reflecting the inhibition of both COX-1- and COX-2-dependent PGE₂ production in the cell culture system. These findings suggest that the mechanism of action of taiwanin C in the inhibition of PGE₂ production is the direct inhibition of COX enzymatic activity.

View all citing articles on Scopus

View full text

Regular ArticleProstaglandin G/H Synthase Isoenzyme 2 Expression in Fibroblasts - Regulation by Dexamethasone, Mitogens, and Oncogenes

Abstract

Regular Article
Prostaglandin G/H Synthase Isoenzyme 2 Expression in Fibroblasts - Regulation by Dexamethasone, Mitogens, and Oncogenes